Dermatology firm in Italy for sale

Company for sale

• Sales: <5 million EUR
• Location: Italy, exact location will be disclosed to seriously interested parties
• Reason for sale: The owners have decided to step out of the business they built, therefore they are willing to talk with strong players in the industry
• #CFIE PHS120

Overview of the dermatology firm in Italy for sale

The company is a niche player in the Western European skin care prescription, skin care formulator, clinical studies, and OTC retail market, with a growing portfolio of clinically tested brands ranging from OTC to prescription to medical device products. The average revenue for the last few years has been at 4 million euros, with a forecast of more than 6 million euros for 2022. Export sales have been growing at a steady pace since 2018 and account for about 10% of the total, with distributors in Asia. The company is looking for strategic investors for a partial sale of its shares.

Profile (strategy) of the dermatology firm in Italy for sale

The company’s strategy is centered on being an R&D-heavy formulator and manufacturer of skin care products, including clinical studies in its scope of operations. Skin care OTC and Rx products account for circa 70% of sales, with the remaining 30% coming from the gynecological, anti-infective line. The company has strong formulation capabilities, and access to more than 4,000 dermatologists, and gynecologists with outsourced sales reps and thousands of pharmacies across its country. The total staff stands at about 15 FTEs.

Established in the mid-90s, initial operations involved the distribution of anti-aging products. The current venue of about 1,000 square meters includes the main office, a warehouse, and 3P logistics. Manufacturing is subcontracted to CMOs, providing products in liquid, semi-solid, and OSD forms. The mid-2000s marked the company’s entry into dermatology pharmaceutical and food supplement products with its own brands. In the last decade, the company has ventured more into medical devices and prescription products.

A new hair loss product was developed and tested clinically in the last three years, having been launched recently. The goal is to get a share of the 100 million euro alopecia market.

The owners seek a partial sale of capital stock to a partner with significant synergies, as turnover increases due to proprietary innovations entering the market from the company’s product research pipeline.

Activities and products of the dermatology firm in Italy for sale

The company has a portfolio of clinically tested brands ranging from OTC to prescription to medical device products. Its product research pipeline is constantly active, and revenue-generating projects are due to come off the drawing board into the market soon.

Skin care OTC and Rx products account for most of the sales, with the remaining coming from the gynecological, and anti-infective lines.

Highlights of the dermatology firm in Italy for sale

• Holder of ISO901 and 13485 certifications, while a GMP application has been filed recently for cosmetics and food supplements
• R&D-focused company with clinical study capability
• Skin care product formulator and manufacturer

Synergies sought include: 

• Growth capital for new product development and more aggressive market penetration in Western Europe
• Complementary product lines across dermatology, gynecology, and skin care cosmetics in general
• Distributor networks in export markets, like other Western European countries, MENA, or Asia

More information on this dermatology firm in Italy for sale

Please get in touch if you are interested in learning more about this dermatology firm in Italy for sale. For more cro companies for sale please visit the section cro companies for sale. For other cro buyers, please visit the section cro companies wanted. If you are instead interested in pharma companies for sale, please visit the pharma companies for sale section. For pharma buyers, please visit the section pharma companies wanted.